Linear Growth Study (0476-097)(COMPLETED)

NCT00395408 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MK0476, montelukast sodium / Duration of Treatment : 56 Weeks
DRUG: Comparator : beclomethasone dipropionate / Duration of Treatment : 56 Weeks

Sponsor

Organon and Co